Innovative drug firms set up three sub-committees

Published: 2013-08-27 06:59:00

Updated: 2013-08-27 06:59:00

The consultative body for 42 innovative drug firms, which belongs to the Korea Pharmaceutical Manufacturers Association (KPMA), held its first meeting last Friday to launch its three sub-committees named “Innovative R&D”, “Innovative Policy and Development” and “Public Relation Cooperation.”

E...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK